ViewpointAdjustment of dosing of antimicrobial agents for bodyweight in adults
References (30)
- et al.
Multicenter evaluation of vancomycin dosing: emphasis on obesity
Am J Med
(2008) - et al.
Pharmacokinetic considerations in obesity
J Pharm Sci
(1999) - et al.
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature
J Hosp Infect
(2006) - et al.
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Int J Antimicrob Agents
(2007) - et al.
Obesity and infection
Lancet Infect Dis
(2006) - et al.
How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport
Clin Chem Lab Med
(2000) - et al.
Quantification of lean bodyweight
Clin Pharmacokinet
(2005) - et al.
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Clin Infect Dis
(2007) - et al.
Prevalence of overweight and obesity in the United States, 1999–2004
JAMA
(2006) - et al.
Obesity prevalence from a European perspective: a systematic review
BMC Public Health
(2008)
“Getting the dose right”: facts, a blueprint, and encouragements
Clin Pharmacol Ther
(2007)
Antimicrobial dosing considerations in obese adult patients
Pharmacotherapy
(2007)
Which weight for weight-based dosage regimens in obese patients?
Am J Health Syst Pharm
(2002)
Interpretation of measured red cell mass and plasma volume in adults: expert panel on radionuclides of the International Council for Standardization in Haematology
Br J Haematol
(1995)
Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects
Br J Clin Pharmacol
(1984)
Cited by (123)
Systematic review and meta-analysis of risk factors for Mesh infection following Abdominal Wall Hernia Repair Surgery
2022, American Journal of SurgeryShould doses of antibiotics be adjusted?
2018, Revue de Medecine InterneTen-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy
2023, American Journal of Gastroenterology
Copyright © 2010 Elsevier Ltd. All rights reserved.